ESMO Clinical Practice Guidelines: Endocrine Cancers
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has two Clinical Practice Guidelines on Endocrine Cancers: Adrenal Cancer and Thyroid Cancer including differentiated thyroid cancer, medullary thyroid cancer, poorly differentiated thyroid cancer and anaplastic thyroid cancer. They include information on: incidence, diagnosis, staging and risk assessment, treatment response evaluation and follow-up.
Adrenal cancer: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii131-vii138.
Authors: A. Berruti, E. Baudin, H. Gelderblom, H. R. Haak, F. Porpiglia, M. Fassnacht, G. Pentheroudakis
Thyroid cancer: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii110-vii119.
Authors: F. Pacini, M. G. Castagna, L. Brilli, G. Pentheroudakis